Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
The document notes that a study on inflammation and social determinants in breast cancer patients is currently recruiting. The conditions in…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Single-Arm Interventional Trial of Pepper- Robot Delivered Cancer Education for Adults With Intellectual Disability [NA]
An interventional, single-arm trial is evaluating Pepper robot-delivered cancer education for adults with intellectual disabilities. The stu…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors [NA]
This clinical trial is evaluating the feasibility of a virtual application to support breast cancer and colorectal cancer survivors and is c…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer [NA]
This document reports a clinical trial update on using omic technologies to track resistance to palbociclib in metastatic breast cancer. The…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System [EARLY_Phase 1]
This Clinical Trial Update indicates that a feasibility evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System for breas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations [Phase 1]
ATV-1601, an investigational therapy, is being studied in a Phase 1 trial for patients with AKT1 E17K-mutant cancers, including breast, cerv…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO) [NA]
A completed clinical trial (REMASCO) evaluating breast reconstruction with functional MRI assessment in breast cancer patients.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating ETX-636 in adults with advanced solid tumors and advanced breast cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors [Phase 2]
A Phase 2 clinical trial of disitamab vedotin in combination with other anticancer drugs for solid tumors is currently recruiting, including…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Influencing Factors and Mechanisms of Capsular Contracture After Prosthesis Reconstruction in Patients With Breast Cancer
A clinical trial exploring factors and mechanisms driving capsular contracture after prosthesis-based breast reconstruction in breast cancer…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer [Phase 2]
Phase 2 results are reported for letrozole in post-menopausal patients with operable hormone-sensitive breast cancer. Results were posted on…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer [Phase 2]
Phase II clinical trial investigating docetaxel with or without nintedanib for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Sentinel Lymph Node Technique in Multifocal Breast Cancer [Phase 2]
Phase 2 trial evaluating the sentinel lymph node biopsy technique in multifocal breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Predicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer. [Phase 2]
Phase 2 trial by the SOLTI Breast Cancer Research Group to predict sensitivity to Olaparib in patients with unresectable locally advanced or…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Engage Psychosocial Intervention for Cancer Symptoms [NA]
Duke University is recruiting for a clinical trial to evaluate an engage psychosocial intervention to help manage cancer-related symptoms ac…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer [Phase 1]
Phase 1 clinical trial update of olaparib in combination with vorinostat in patients with relapsed/refractory and/or metastatic breast cance…
-
FDA approval · 2026-03-16FDA Approved: ERIBULIN MESYLATE — Original Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved the Original Application for ERIBULIN MESYLATE (generic) by XGen Pharmaceuticals DJB, Inc.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Psychometric Validation (Quality-of-life Scale) in Young Women With a Non Metastatic Breast Cancer and Her Partner
This clinical trial update reports psychometric validation of a quality-of-life scale for young women with non-metastatic breast cancer and …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating multiple treatment combinations in patients with metastatic or locally advanced breast cancer; the stu…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib [Phase 3]
A Phase 3 clinical trial is evaluating chemotherapy de-escalation in HR-positive, HER2-negative intermediate-risk early breast cancer treate…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients [Phase 1]
Phase 1 trial evaluating the combination of ipatasertib, pertuzumab, and trastuzumab in advanced HER2-positive, PI3KCA-mutant metastatic bre…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating sacituzumab govitecan in combination with talazoparib for metastatic breast cancer; the study is cu…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors [Phase 1]
Phase 1 study evaluating ALRN-6924 in combination with paclitaxel in patients with advanced, unresectable solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Imaging Evaluation of the Therapeutic Response of Breast Cancer Bone Metastasis (EMOS)
The EMOS trial, investigating imaging-based assessment of therapeutic response in breast cancer with bone metastases, has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer. [Phase 1, Phase 2]
An update on a Phase 1/2 trial evaluating the combination of alpelisib and tucatinib in patients with PIK3CA-mutant, HER2-positive metastati…